Measuring addiction propensity and severity: The need for a new instrument

Drug and Alcohol Dependence

Volumn 111, Issue 1-2, 2010, Pages 4-12

  Conway, Kevin P ^a   Levy, Janet ^b   Vanyukov, Michael ^c   Chandler, Redonna ^a   Rutter, Joni ^a   Swan, Gary E ^d   Neale, Michael ^e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b DUKE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d SRI INTERNATIONAL   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Cannabis assessment; Individual differences; Tobacco

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; OPIATE;

ADDICTION SEVERITY INDEX; ALCOHOL DEPENDENCE SCALE; ALCOHOLISM; CHEMICAL USE ABUSE AND DEPENDENCE SCALE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG USE SCREENING INVENTORY; GLOBAL APPRAISAL OF INDIVIDUAL NEEDS; HUMAN; INSTRUMENT VALIDATION; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SCREENING TEST; SEVERITY OF ALCOHOL DEPENDENCE QUESTIONNAIRE; SEVERITY OF DEPENDENCE SCALE; SUBSTANCE DEPENDENCE SEVERITY SCALE; SUBSTANCE USE INVOLVEMENT INDEX; TRANSMISSIBLE LIABILITY INDEX;

HUMANS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RISK; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

CANNABIS; NICOTIANA TABACUM;

EID: 77956190009     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.03.011     Document Type: Review

References (126)

1. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv. Rev. Psychiatry 2004, 12:305-320.
2. Baillie A.J., Mattick R.P. The benzodiazepine dependence questionnaire: development, reliability and validity. Br. J. Psychiatry 1996, 169:276-281.
3. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger J.I., Porjesz B., Schuckit M.A., Reich T. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry 1998, 55:982-988.
4. Brody G.H., Beach S.R., Philibert R.A., Chen Y.F., Lei M.K., Murry V.M., Brown A.C. Parenting moderates a genetic vulnerability factor in longitudinal increases in youths' substance use. J. Consult. Clin. Psychol. 2009, 77:1-11.
5. Button T.M., Hewitt J.K., Rhee S.H., Young S.E., Corley R.P., Stallings M.C. Examination of the causes of covariation between conduct disorder symptoms and vulnerability to drug dependence. Twin Res. Hum. Genet. 2006, 9:38-45.
6. Cadoret R.J., Yates W.R., Troughton E., Woodworth G., Stewart M.A. Adoption study demonstrating two genetic pathways to drug abuse. Arch. Gen. Psychiatry 1995, 52:42-52.
7. Chan Y.F., Dennis M.L., Funk R.R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J. Subst. Abuse Treat. 2008, 34:14-24.
8. Chassin L., Rogosch F., Barrera M. Substance use and symptomatology among adolescent children of alcoholics. J. Abnorm. Psychol. 1991, 100:449-463.
9. Churchill A.C., Burgess P.M., Pead J., Gill T. Measurement of the severity of amphetamine dependence. Addiction 1993, 88:1335-1340.
10. Compton W.M., Saha T.D., Conway K.P., Grant B.F. The role of cannabis use within a dimensional approach to cannabis use disorders. Drug Alcohol Depend. 2009, 100:221-227.
11. Conway K.P., Kane R.J., Ball S.A., Poling J.C., Rounsaville B.J. Personality, substance of choice, and polysubstance involvement among substance dependent patients. Drug Alcohol Depend. 2003, 71:65-75.
12. Conway K.P., Swendsen J.D., Rounsaville B.J., Merikangas K.R. Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug Alcohol Depend. 2002, 65:225-234.
13. Conway K.P., Compton W.M., Miller P.M. Editorial: Novel approaches to phenotyping drug abuse. Addict. Behav. 2006, 31:923-928.
14. Craddock N., O'Donovan M.C., Owen M.J. Genome-wide association studies in psychiatry: lessons from early studies of non-psychiatric and psychiatric phenotypes. Mol. Psychiatry 2008, 13:649-653.
15. Dawson D.A., Grant B.F., Stinson F.S., Chou P.S. Maturing out of alcohol dependence: the impact of transitional life events. J. Stud. Alcohol 2006, 67:195-203.
16. Dennis M., Scott C.K. Managing addiction as a chronic condition. Addict. Sci. Clin. Pract. 2007, 4:45-55.
17. Dennis M., Titus J., Unsicker J., Hodkgins D. Global Appraisal of Individual Needs: Administration Guide for the GAIN and Related Measures 2003, Chestnut Health Systems, Bloomington, IL.
18. Dennis M.L., Chan Y.F., Funk R.R. Development and validation of the GAIN short screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am. J. Addict. 2006, 15:80-91.
19. Dennis M.L., Scott C.K., Funk R., Foss M.A. The duration and correlates of addiction and treatment careers. J. Subst. Abuse Treat. 2005, 28(Suppl. 1):S51-S62.
20. Dick D.M., Aliev F., Wang J.C., Grucza R.A., Schuckit M., Kuperman S., Kramer J., Hinrichs A., Bertelsen S., Budde J.P., Hesselbrock V., Porjesz B., Edenberg H.J., Bierut L.J., Goate A. Using dimensional models of externalizing psychopathology to aid in gene identification. Arch. Gen. Psychiatry 2008, 65:310-318.
21. Drasgow F., Olson-Buchanan J.B. Innovations in Computerized Assessment 1999, Lawrence Erlbaum Associates, Mahwah.
22. Edwards G., Gross M.M. Alcohol dependence-provisional description of a clinical syndrome. Br. Med. J. 1976, 1:1058-1061.
23. Elkins I.J., McGue M., Malone S., Iacono W.G. The effect of parental alcohol and drug disorders on adolescent personality. Am. J. Psychiatry 2004, 161:670-676.
24. Embretson S.E., Reise W.S.P. Item Response Theory for Psychologists 2000, Lawrence Erlbaum Associates, Mahwah, NJ.
25. Falconer D.S. The inheritance of liability to certain diseases, estimate from the incidence among relatives. Ann. Hum. Genet. 1965, 29:51-71.
26. Foll B.L., Gallo A., Le S.Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav. Pharmacol. 2009, 20:1-17.
27. Gillespie N.A., Neale M.C., Prescott C.A., Aggen S.H., Kendler K.S. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids. Addiction 2007, 102:920-930.
28. Gilmore C.S., Malone S.M., Bernat E.M., Iacono W.G. Relationship between the P3 event-related potential, its associated time-frequency components, and externalizing psychopathology. Psychophysiology 2009.
29. Glantz M.D., Conway K.P., Colliver J.D. Drug abuse heterogeneity and the search for subtypes. Epidemiology of Drug Abuse 2005, 15-28. Kluwer Academic/Plenum Publishers, New York. Z. Sloboda (Ed.).
30. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
31. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (Sds)-psychometric properties of the Sds in English and Austrian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
32. Hambleton R.K., Swaminathan H.S. Item Response Theory Principles and Applications 1985, Kluwer Nijhoff Publishing, Boston.
33. Hambleton R.K., Swaminathan H., Rogers H.J. Fundamentals of item response theory 1991, Sage, Newbury Park, CA.
34. Hariri A.R. The neurobiology of individual differences in complex behavioral traits. Annu. Rev. Neurosci. 2009, 32:225-247.
35. Hariri A.R., Gorka A., Hyde L.W., Kimak M., Halder I., Ducci F., Ferrell R.E., Goldman D., Manuck S.B. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol. Psychiatry 2008.
36. Hawkins J.D., Catalano R.F., Miller J.Y. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood-implications for substance-abuse prevention. Psychol. Bull. 1992, 112:64-105.
37. Hawkins J.D., Kosterman R., Catalano R.F., Hill K.G., Abbott R.D. Effects of social development intervention in childhood 15 years later. Arch. Pediatr. Adolesc. Med. 2008, 162:1133-1141.
38. Hicks B.M., Bernat E., Malone S.M., Iacono W.G., Patrick C.J., Krueger R.F., McGue M. Genes mediate the association between P3 amplitude and externalizing disorders. Psychophysiology 2007, 44:98-105.
39. Hicks, B.M., Iacono, W.G., McGue, M., in press. Index of the transmissible common liability to addiction: heritability and prospective associations with substance abuse and related outcomes. Addiction.
40. Hicks B.M., Krueger R.F., Iacono W.G., McGue M., Patrick C.J. Family transmission and heritability of externalizing disorders: a twin-family study. Arch. Gen. Psychiatry 2004, 61:922-928.
41. Hodgins D.C., Elguebaly N. More data on the addiction severity index-reliability and validity with the mentally-Ill substance-abuser. J. Nerv. Ment. Dis. 1992, 180:197-201.
42. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29:565-598.
43. Iacono W.G., Carlson S.R., Malone S.M., McGue M. P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Arch. Gen. Psychiatry 2002, 59:750-757.
44. Iacono W.G., Carlson S.R., Taylor J., Elkins I.J., McGue M. Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev. Psychopathol. 1999, 11:869-900.
45. Iacono W.G., Malone S.M., McGue M. Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu. Rev. Clin. Psychol. 2008, 4:325-348.
46. Justus A.N., Finn P.R., Steinmetz J.E. P300, disinhibited personality, and early-onset alcohol problems. Alcohol. Clin. Exp. Res. 2001, 25:1457-1466.
47. Kahler C.W., Strong D.R., Hayaki J., Ramsey S.E., Brown R.A. An item response analysis of the alcohol dependence scale in treatment-seeking alcoholics. J. Stud. Alcohol 2003, 64:127-136.
48. Kahler C.W., Strong D.R., Stuart G.L., Moore T.M., Ramsey S.E. Item functioning of the alcohol dependence scale in a high-risk sample. Drug Alcohol Depend. 2003, 72:183-192.
49. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2007, 33:166-180.
50. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162:1403-1413.
51. Kellam S.G., Brown C.H., Poduska J.M., Ialongo N.S., Wang W., Toyinbo P., Petras H., Ford C., Windham A., Wilcox H.C. Effects of a universal classroom behavior management program in first and second grades on young adult behavioral, psychiatric, and social outcomes. Drug Alcohol Depend. 2008, 95(Suppl. 1):S5-S28.
52. Kendler K.S., Karkowski L.M., Neale M.C., Prescott C.A. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry 2000, 57:261-269.
53. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry 2003, 160:687-695.
54. Kendler K.S., Myers J., Prescott C.A. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch. Gen. Psychiatry 2007, 64:1313-1320.
55. Kendler K.S., Prescott C.A., Myers J., Neale M.C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 2003, 60:929-937.
56. Kirillova G.P., Vanyukov M.M., Kirisci L., Reynolds M. Physical maturation, peer environment, and the ontogenesis of substance use disorders. Psychiatry Res. 2008, 158:43-53.
57. Kirisci, L., Hsu, T., 1992. Ability Estimation Using Only Observable Quantities in Adaptive Testing. ERIC Document Reproduction Service No. TM 018393.
58. Kirisci L., Mezzich A., Tarter R. Norms and sensitivity of the adolescent version of the drug-use screening inventory. Addict. Behav. 1995, 20:149-157.
59. Kirisci L., Tarter R., Mezzich A., Ridenour T., Reynolds M., Vanyukov M. Prediction of cannabis use disorder between boyhood and young adulthood clarifying the phenotype and environtype. Am. J. Addict. 2009, 18:36-47.
60. Kirisci L., Tarter R.E., Vanyukov M., Martin C., Mezzich A., Brown S. Application of item response theory to quantify substance use disorder severity. Addict. Behav. 2006, 31:1035-1049.
61. Kirisci L., Vanyukov M., Dunn M., Tarter R. Item response theory modeling of substance use: an index based on 10 drug categories. Psychol. Addict. Behav. 2002, 16:290-298.
62. Koob G.F., Le M.M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
63. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2009.
64. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005, 8:1450-1457.
65. Krueger R.F., Hicks B.M., Patrick C.J., Carlson S.R., Iacono W.G., McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J. Abnorm. Psychol. 2002, 111:411-424.
66. Krueger R.F., Markon K.E., Patrick C.J., Benning S.D., Kramer M.D. Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum. J. Abnorm. Psychol. 2007, 116:645-666.
67. Langbehn D.R., Cadoret R.J., Caspers K., Troughton E.P., Yucuis R. Genetic and environmental risk factors for the onset of drug use and problems in adoptees. Drug Alcohol Depend. 2003, 69:151-167.
68. Langenbucher J.W., Morgenstern J., Miller K.J. Dsm-Iii, Dsm-Iv and Icd-10 as severity scales for drug-dependence. Drug Alcohol Depend. 1995, 39:139-150.
69. Li M.D., Burmeister M. New insights into the genetics of addiction. Nat. Rev. Genet. 2009, 10:225-231.
70. Lord F.M., Novick M.R. Statistical Theories of Mental Test Scores 1968, Addison-Wesley Publishing Company, Reading, MA.
71. McDermott P.A., Alterman A.I., Brown L., Zaballero A., Snider E.C., Mckay J.R. Construct refinement and confirmation for the addiction severity index. Psychol. Assess. 1996, 8:182-189.
72. Mcgovern M.P., Morrison D.H. The Chemical Use, Abuse, and Dependence Scale (Cuad)-rationale, reliability, and validity. J. Subst. Abuse Treat. 1992, 9:27-38.
73. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., Obrien C.P. New data from the addiction severity index-reliability and validity in 3 centers. J. Nerv. Ment. Dis. 1985, 173:412-423.
74. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J. Nerv. Ment. Dis. 1980, 168:26-33.
75. Merikangas K.R., Conway K.P. Genetic epidemiology of substance use disorders. Neurobiology of Mental Illness 2009, 786-800. Oxford University Press, New York. D.S. Charney, E.J. Nester (Eds.).
76. Merikangas K.R., Conway K.P. Genetic epidemiology of substance use disorders. Neurobiology of Mental Illness 2008, third. D.S. Charney, E.J. Nester (Eds.).
77. Merikangas K.R., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., Zhang H., O'Malley S.S., Rounsaville B.J. Familial transmission of substance use disorders. Arch. Gen. Psychiatry 1998, 55:973-979.
78. Merikangas K.R., Avenevoli S. Implications of genetic epidemiology for the prevention of substance use disorders. Addict. Behav. 2000, 25:807-820.
79. Miele G.M., Carpenter K.M., Cockerham M.S., Trautman K.D., Blaine J., Hasin D.S. Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000, 59:63-75.
80. Moffitt T.E. Genetic and environmental influences on antisocial behaviors: evidence from behavioral-genetic research. Adv. Genet. 2005, 55:41-104.
81. Mustanski B.S., Viken R.J., Kaprio J., Rose R.J. Genetic influences on the association between personality risk factors and alcohol use and abuse. J. Abnorm. Psychol. 2003, 112:282-289.
82. Neale M.C., Aggen S.H., Maes H.H., Kubarych T.S., Schmitt J.E. Methodological issues in the assessment of substance use phenotypes. Addict. Behav. 2006, 31:1010-1034.
83. Newcomb M.D., Galaif E.R., Locke T.F. Substance use diagnoses within a community sample of adults: distinction, comorbidity, and progression over time. Prof. Psychol.: Res. Pract. 2001, 32:239-247.
84. O'Brien C.P. Research advances in the understanding and treatment of addiction. Am. J. Addict. 2003, 12:S36-S47.
85. Patkar A.A., Mannelli P., Peindl K., Hill K.P., Wu L.T., Lee T., Kuhn C. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. J. Psychiatr. Res. 2008, 42:1213-1219.
86. Poduska J.M., Kellam S.G., Wang W., Brown C.H., Ialongo N.S., Toyinbo P. Impact of the Good Behavior Game, a universal classroom-based behavior intervention, on young adult service use for problems with emotions, behavior, or drugs or alcohol. Drug Alcohol Depend. 2008, 95(Suppl. 1):S29-S44.
87. Reich T., Cloninger C.R., Van E.P., Rice J.P., Mullaney J. Secular trends in the familial transmission of alcoholism. Alcohol. Clin. Exp. Res. 1988, 12:458-464.
88. Riley B.B., Conrad K.J., Bezruczko N., Dennis M.L. Relative precision, efficiency and construct validity of different starting and stopping rules for a computerized adaptive test: the GAIN substance problem scale. J. Appl. Meas. 2007, 8.
89. Romer D., Walker E.F. Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science 2007, Oxford University Press, New York.
90. Saha T.D., Stinson F.S., Grant B.F. The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Depend. 2007, 89:82-92.
91. Saxon A.J., Oreskovich M.R., Brkanac Z. Genetic determinants of addiction to opioids and cocaine. Harv. Rev. Psychiatry 2005, 13:218-232.
92. Schuckit M.A. An overview of genetic influences in alcoholism. J. Subst. Abuse Treat. 2009, 36:S5-S14.
93. Schuckit M.A., Goodwin D.A., Winokur G. A study of alcoholism in half siblings. Am. J. Psychiatry 1972, 128:1132-1136.
94. Sher K.J., Bartholow B.D., Wood M.D. Personality and substance use disorders: a prospective study. J. Consult. Clin. Psychol. 2000, 68:818-829.
95. Skinner H.A., Allen B.A. Alcohol dependence syndrome-measurement and validation. J. Abnorm. Psychol. 1982, 91:199-209.
96. Slutske W.S., Heath A.C., Madden P.A., Bucholz K.K., Statham D.J., Martin N.G. Personality and the genetic risk for alcohol dependence. J. Abnorm. Psychol. 2002, 111:124-133.
97. Stockwell T., Hodgson R., Edwards G., Taylor C., Rankin H. Development of a questionnaire to measure severity of alcohol dependence. Br. J. Addict. 1979, 74:79-87.
98. Strong D.R., Brown R.A., Ramsey S.E., Myers M.G. Nicotine dependence measures among adolescents with psychiatric disorders: evaluating symptom expression as a function of dependence severity. Nicotine Tob. Res. 2003, 5:735-746.
99. Strong D.R., Kahler C.W., Abrantes A.M., MacPherson L., Myers M.G., Ramsey S.E., Brown R.A. Nicotine dependence symptoms among adolescents with psychiatric disorders: using a Rasch model to evaluate symptom expression across time. Nicotine Tob. Res. 2007, 9:557-569.
100. Strong D.R., Kahler C.W., Colby S.M., Griesler P.C., Kandel D. Linking measures of adolescent nicotine dependence to a common latent continuum. Drug Alcohol Depend. 2009, 99:296-308.
101. Strong D.R., Kahler C.W., Ramsey S.E., Brown R.A. Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysis. Drug Alcohol Depend. 2003, 72:151-162.
102. Sutherland G., Edwards G., Taylor C., Phillips G., Gossop M., Brady R. The measurement of opiate dependence. Br. J. Addict. 1986, 81:485-494.
103. Swendsen J.D., Conway K.P., Rounsaville B.J., Merikangas K.R. Are personality traits familial risk factors for substance use disorders? Results of a controlled family study. Am. J. Psychiatry 2002, 159:1760-1766.
104. Tarter R.E., Kirisci L., Habeych M., Reynolds M., Vanyukov M. Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways. Drug Alcohol Depend. 2004, 73:121-132.
105. Tarter R.E., Kirisci L., Mezzich A., Cornelius J.R., Pajer K., Vanyukov M., Gardner W., Blackson T., Clark D. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am. J. Psychiatry 2003, 160:1078-1085.
106. Tarter R.E., Laird S.B., Kabene M., Bukstein O., Kaminer Y. Drug-abuse severity in adolescents is associated with magnitude of deviation in temperament traits. Br. J. Addict. 1990, 85:1501-1504.
107. Tarter R.E., Vanyukov M. Theoretical and operational framework for research into the etiology of substance use disorders. J. Child Adoles. Subst. Abuse 1991, 10:1-12.
108. Tarter R.E., Vanyukov M. Alcoholism: a developmental disorder. J. Consult. Clin. Psychol. 1994, 62:1096-1107.
109. Tarter R.E., Vanyukov M., Kirisci L., Reynolds M., Clark D.B. Predictors of marijuana use in adolescents before and after licit drug use: examination of the gateway hypothesis. Am. J. Psychiatry 2006, 163:2134-2140.
110. Topp L., Mattick R.P. Validation of the amphetamine dependence syndrome and the SamDQ. Addiction 1997, 92:151-162.
111. Tsuang M.T., Lyons M.J., Eisen S.A., Goldberg J., True W., Lin N., Meyer J.M., Toomey R., Faraone S.V., Eaves L. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am. J. Med. Genet. 1996, 67:473-477.
112. Tsuang M.T., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., True W., Lin N., Toomey R., Eaves L. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry 1998, 55:967-972.
113. Uhl G.R. Molecular Genetics of Substance Abuse Vulnerability: Remarkable Recent Convergence of Genome Scan Results 2004, New York Acad Sciences, New York.
114. Uhl G.R., Drgon T., Liu Q.R., Johnson C., Walther D., Komiyama T., Harano M., Sekine Y., Inada T., Ozaki N., Iyo M., Iwata N., Yamada M., Sora I., Chen C.K., Liu H.C., Ujike H., Lin S.K. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 2008, 65:345-355.
115. Vanyukov M., Kirisci L., Moss L., Tarter R.E., Reynolds M., Maher B.S., Kirillova G.P., Ridenour T., Clark D.B. Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability. Behav. Genet. 2009, 39:233-244.
116. Vanyukov M.M., Kirisci L., Tarter R.E., Simkevitz H.F., Kirillova G.P., Maher B.S., Clark D.B. Liability to substance use disorders: 2. A measurement approach. Neurosci. Biobehav. Rev. 2003, 27:517-526.
117. Vanyukov M.M., Maher B.S., Devlin B., Kirillova G.P., Kirisci L., Yu L.M., Ferrell R.E. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. Psychiatr. Genet. 2007, 17:323-332.
118. Vanyukov M.M., Tarter R.E. Genetic studies of substance abuse. Drug Alcohol Depend. 2000, 59:101-123.
119. Vanyukov M.M., Tarter R.E., Kirisci L., Kirillova G.P., Maher B.S., Clark D.B. Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci. Biobehav. Rev. 2003, 27:507-515.
120. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain: insights from imaging studies. J. Clin. Invest. 2003, 111:1444-1451.
121. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9:557-569.
122. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., Wong C. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 2006, 26:6583-6588.
123. Winokur G., Reich T., Rimmer J., Pitts F.N. Alcoholism. 3. Diagnosis and familial psychiatric illness in 259 alcoholic probands. Arch. Gen. Psychiatry 1970, 23:104-111.
124. Wu L.T., Pan J.J., Blazer D.G., Tai B., Stitzer M.L., Brooner R.K., Woody G.E., Patkar A.A., Blaine J.D. An item response theory modeling of alcohol and marijuana dependences: A National Drug Abuse Treatment Clinical Trials Network study. J. Stud. Alcohol Drugs 2009, 70:414-425.
125. Young S.E., Friedman N.P., Miyake A., Willcutt E.G., Corley R.P., Haberstick B.C., Hewitt J.K. Behavioral disinhibition: liability for externalizing spectrum disorders and its genetic and environmental relation to response inhibition across adolescence. J. Abnorm. Psychol. 2009, 118:117-130.
126. Young S.E., Stallings M.C., Corley R.P., Krauter K.S., Hewitt J.K. Genetic and environmental influences on behavioral disinhibition. Am. J. Med. Genet. 2000, 96:684-695.